This inventor holds 1 USPTO granted patent. Top assignee: Creagene Inc.. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Innovations of Jung-Hwan Kim
Introduction
Jung-Hwan Kim is a notable inventor based in Daejeon Metropolitan, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of cytoplasmic transduction peptides.
Latest Patents
His most recent patent is titled "Cytoplasmic transduction peptides and uses thereof." This invention relates to a cytoplasmic transduction peptide (CTP) that demonstrates transduction potential, as well as cytoplasmic remaining potential and various applications. The CTP exhibits a transduction potential that is equal to or greater than conventional protein transduction, known as PTD, and shows a strong tendency to remain in the cytoplasm. This makes it particularly useful for inducing cytotoxic T lymphocytes (CTL) and for drug delivery systems (DDS) targeting the cytoplasm.
Career Highlights
Jung-Hwan Kim is currently associated with Creagene Inc., where he continues to innovate and develop new technologies. His work has positioned him as a key figure in the biotechnology sector.
Collaborations
He collaborates with talented individuals such as Dae-You Kim and Hae-Keun Oh, contributing to a dynamic research environment.
Conclusion
Jung-Hwan Kim's innovative work in cytoplasmic transduction peptides showcases his commitment to advancing biotechnology. His contributions are paving the way for new therapeutic approaches and drug delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile